# Muscle on a GLP-1: how much of the weight lost is lean mass?

Source: https://pepvault.app/guides/muscle-on-a-glp-1

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Muscle on a GLP-1: how much of the weight lost is lean mass?

Reviewed November 2026 10 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

How much weight lost on a GLP-1 is lean mass: SURMOUNT-1, STEP 1, the apitegromab and bimagrumab add-on trials, and what guidance says on protein and training.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 10
- **Questions:** 7
- **Compounds:** 4

## The short answer

In the trials, about a quarter to two-fifths of the weight lost on tirzepatide or semaglutide was lean mass, roughly the share any large weight loss takes, and lean mass is more than muscle. The 2025 nutrition advisory pairs the drug with protein, 1.2 to 1.6 g per kg a day proposed during active weight loss, and strength training at least three times a week.

Every number checked at its primary source · Nov 20, 2026 · [10 sources](https://pepvault.app/guides/muscle-on-a-glp-1#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Randomised trials in people: DXA substudies of the phase 3 SURMOUNT-1 and STEP 1 trials, the phase 2 BELIEVE and EMBRAZE add-on trials, and a one-year liraglutide and exercise trial, a phase 2 retatrutide DXA substudy, plus a 2025 joint advisory and a 2026 review; tirzepatide, semaglutide and liraglutide are FDA-approved for weight management, apitegromab is FDA-approved only for spinal muscular atrophy, and bimagrumab and retatrutide are investigational.

## How much of the weight lost on a GLP-1 is lean mass?

Most of it is fat. In the body-composition substudy of SURMOUNT-1, 160 people had a DXA scan (a low-dose X-ray scan that splits the body into fat, bone and everything else) at the start and after 72 weeks. On tirzepatide, fat mass fell 33.9% and lean mass 10.9%, against 8.2% and 2.6% on placebo. Of the weight lost, 74% was fat and 26% lean on tirzepatide, and 75% and 25% on placebo[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1).

Semaglutide's trials put the lean share higher. In STEP 1's DXA group, people on 2.4 mg lost 9.3 kg of fat and 5.8 kg of lean mass by week 68[2](https://pepvault.app/guides/muscle-on-a-glp-1#source-2), about 38% of the tissue lost, the figure the 2025 nutrition advisory gives for the same trial[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6). Lilly's BELIEVE trial, with semaglutide 2.4 mg as one of its arms, measured about 29% at week 48[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3) [4](https://pepvault.app/guides/muscle-on-a-glp-1#source-4). The table lines the trials up.

| Trial and group | Weight lost | Lean mass lost | Lean share of the loss |
| --- | --- | --- | --- |
| SURMOUNT-1, tirzepatide 5 to 15 mg, 72 weeks | 21.3% | 5.6 kg (10.9%) | 26%[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1) |
| SURMOUNT-1, placebo, 72 weeks | 5.3% | 1.2 kg (2.6%) | 25%[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1) |
| STEP 1, semaglutide 2.4 mg, 68 weeks | 15.5 kg | 5.8 kg | About 38%[2](https://pepvault.app/guides/muscle-on-a-glp-1#source-2) [6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6) |
| BELIEVE, semaglutide 2.4 mg alone, 48 weeks | 14.2 kg | 4.4 kg | About 29%[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3) [4](https://pepvault.app/guides/muscle-on-a-glp-1#source-4) |
| BELIEVE, bimagrumab plus semaglutide 2.4 mg, 48 weeks | 17.8 kg | 1.4 kg | About 8%[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3) [4](https://pepvault.app/guides/muscle-on-a-glp-1#source-4) |
| EMBRAZE, tirzepatide with placebo, 24 weeks | 12.5 kg | 3.5 kg | 30.2%[5](https://pepvault.app/guides/muscle-on-a-glp-1#source-5) |
| EMBRAZE, tirzepatide with apitegromab, 24 weeks | 11.2 kg | 1.6 kg | 14.6%[5](https://pepvault.app/guides/muscle-on-a-glp-1#source-5) |

Look at the lean segment: a quarter to two-fifths on the GLP-1 drugs alone, the same quarter on SURMOUNT-1's placebo, and smaller in the two add-on arms.

The shares are not a straight drug-to-drug comparison: the trials ran for different lengths of time in different people, and BELIEVE reports the fat share of fat plus lean loss (the lean share here is the remainder)[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3). For STEP 1, the share is lean mass over the fat and lean mass lost[2](https://pepvault.app/guides/muscle-on-a-glp-1#source-2); SURMOUNT-1's paper, working from STEP 1's main publication, puts it at 40%[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1).

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

In PepVault, Food sets your daily protein target; on a weight-loss goal it is 1.6 g per kg of your goal weight while you are above it.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Is lean mass the same as muscle?

No. On a DXA scan, lean mass is everything that is neither fat nor bone: skeletal muscle, but also the organs, connective tissue, body water and the water stored with glycogen, the body's carbohydrate reserve. So a drop in lean mass is not a one-to-one measure of muscle lost, and early changes partly reflect water and glycogen[8](https://pepvault.app/guides/muscle-on-a-glp-1#source-8). SURMOUNT-1's paper defines it the same way, as fat-free mass minus bone[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1).

Muscle is about half of lean body mass, so the advisory reads STEP 1's 38% lean share as roughly 20% of the weight lost being muscle[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6). The scan also misses what it cannot see: it does not measure fat inside the muscle or how strong the muscle is, which is why a 2026 review judges muscle on mass, strength and quality together[8](https://pepvault.app/guides/muscle-on-a-glp-1#source-8).

A DXA scan's 'lean mass' is the whole right-hand block. Muscle is only part of it.

## Do GLP-1s take more muscle than an ordinary diet?

By share, no. Everyone in SURMOUNT-1 had diet and activity counselling, aiming at a 500 kcal daily deficit and 150 minutes of activity a week with no strength programme. The placebo group, on that advice alone, lost the same quarter as lean mass as the tirzepatide group did, while losing far less weight[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1). The split held across sex, age and size of weight loss, at 70 to 76% fat with tirzepatide in every subgroup[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1). The advisory notes the losses track the amount of weight lost and match what bariatric surgery and very low-calorie diets do[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6). Retatrutide, an investigational triple agonist, looks the same so far: in its 36-week DXA substudy in people with type 2 diabetes, the lean share of the weight lost was similar to other obesity treatments[10](https://pepvault.app/guides/muscle-on-a-glp-1#source-10).

What does grow is the amount, because more weight comes off. In SURMOUNT-1, 5.6 kg of lean mass went with tirzepatide against 1.2 kg on placebo[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1). The advisory adds that the loss also depends on how hard calories are cut, how fast the weight comes off, and whether you strength-train[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6).

## With this guide

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)
- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

## Does losing lean mass make you weaker?

The trials so far have not shown it. People on tirzepatide in SURMOUNT-1 reported better physical function despite the lean mass they lost[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1). The flip side holds too: the add-on drugs below kept lean mass, yet in BELIEVE grip strength on the high-dose combination rose no more than on placebo, and only one combination group (bimagrumab with semaglutide 1.0 mg) gained significantly[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3), while EMBRAZE saw no notable difference in physical function[5](https://pepvault.app/guides/muscle-on-a-glp-1#source-5).

The concern is sharper for some people. The advisory names older age, perimenopause or menopause, lower testosterone, sitting most of the day, low protein intake and no strength training as raising the risk of muscle loss[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6), and SURMOUNT-1's authors flag older adults with, or at risk of, sarcopenic obesity, which is low muscle alongside excess fat[1](https://pepvault.app/guides/muscle-on-a-glp-1#source-1). If everyday things such as stairs or getting up from a chair get harder while the weight comes off, raise it with your prescriber.

## What did the apitegromab and bimagrumab trials try?

Both add a muscle-sparing antibody to the weight-loss drug, and neither is approved for weight loss or for muscle on a GLP-1. Bimagrumab is investigational; apitegromab's one approval, from September 2026, is for spinal muscular atrophy, a rare inherited muscle-wasting disease[9](https://pepvault.app/guides/muscle-on-a-glp-1#source-9). Apitegromab blocks the activation of myostatin, a growth factor that regulates the breakdown of skeletal muscle[5](https://pepvault.app/guides/muscle-on-a-glp-1#source-5). In EMBRAZE, a phase 2 trial in 102 adults, everyone took tirzepatide and half also had apitegromab. At week 24 weight loss was similar, but the apitegromab group lost 1.6 kg of lean mass against 3.5 kg, keeping 1.9 kg more, which the authors call 54.9% retention[5](https://pepvault.app/guides/muscle-on-a-glp-1#source-5). Eight weeks after both drugs stopped, the gap was 0.9 kg[5](https://pepvault.app/guides/muscle-on-a-glp-1#source-5).

Bimagrumab blocks the type II activin receptors, which carry myostatin's signal and the signal from activin A[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3). BELIEVE randomised 507 adults to nine groups, mixing bimagrumab, semaglutide and placebo. At week 48 the high-dose combination took off 17.8 kg against 14.2 kg on semaglutide 2.4 mg alone, and 92.3% of the fat and lean mass lost was fat, against 71.1%[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3) [4](https://pepvault.app/guides/muscle-on-a-glp-1#source-4). Bimagrumab alone added a little lean mass[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3). Muscle spasms, diarrhoea and acne were its common side effects[3](https://pepvault.app/guides/muscle-on-a-glp-1#source-3).

## Do protein and exercise protect muscle on a GLP-1?

Training is the better-supported half. Structured strength training, alone or mixed with aerobic work, is well established to help keep lean mass during weight loss, and aerobic exercise alone does less[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6). The advisory is blunt on protein: more of it alone is likely not enough to keep muscle without structured resistance training[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6).

One randomised trial of a GLP-1 plus exercise used liraglutide, an older daily GLP-1. After an eight-week low-calorie diet, 195 adults spent a year on exercise, liraglutide, both or neither. The combination lowered body-fat percentage by 3.9 points, about twice either one alone, and only the combination improved insulin sensitivity and fitness[7](https://pepvault.app/guides/muscle-on-a-glp-1#source-7). Its exercise was a moderate-to-vigorous programme, and its body-composition end point was body-fat percentage, not muscle[7](https://pepvault.app/guides/muscle-on-a-glp-1#source-7).

**Commonly reported:** protein being the hardest target to reach when appetite is low, eating the protein part of a meal first or using shakes and yoghurt to close the gap, and lifts holding steady in the gym while the scale keeps dropping.

## How much protein and training does the guidance propose?

These are the 2025 joint advisory's figures for people taking GLP-1 medicines, from four US obesity and nutrition societies: published ranges, not a prescription[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6).

1. Find your protein range: the advisory lists 0.8 g per kg a day as the adult allowance and 1.2 to 1.6 g per kg a day as proposed during active weight loss[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6). The GLP-1 protein calculator on this site does the sum from the weight you type in: set to 200 lb (91 kg) and "Losing weight", it multiplies by 1.2 and 1.6 and gives 109 to 145 g a day. With obesity, your actual weight can overstate the need, and the advisory leaves open which weight to use[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6).
2. If counting per kg is a chore, use the advisory's simpler absolute target of 80 to 120 g a day[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6).
3. Eat the protein part of each meal first, so it goes in before your appetite runs out[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6).
4. Keep your intake between the advisory's bounds: not below 0.4 to 0.5 g per kg a day, and not at 2 g per kg a day or more for long periods[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6).
5. Plan strength training at least three times a week, plus at least 150 minutes of moderate aerobic exercise, matched to your fitness level, which is what the advisory aims for alongside the drug[6](https://pepvault.app/guides/muscle-on-a-glp-1#source-6).

The per-kg range and the advisory's simpler absolute target, side by side.

<!--promo-->

In PepVault, Food sets your daily protein target; on a weight-loss goal it is 1.6 g per kg of your goal weight while you are above it. [Track your food in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-muscle-on-a-glp-1-inline&mt=8)

<!--/promo-->

<!--promo-->

Training holds your weekly plan and logs each session you do, so the three strength days are on the page. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-muscle-on-a-glp-1-inline&mt=8)

<!--/promo-->

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025;27(5):2720-2729. Correction (Figure 4's axis label): 2025;27(11):6823. [PubMed 39996356](https://pubmed.ncbi.nlm.nih.gov/39996356/)
2. Novo Nordisk A/S. STEP 1: semaglutide 2.4 mg in people with overweight or obesity (NCT03548935). ClinicalTrials.gov results: body composition by DXA, baseline to week 68. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03548935)
3. Heymsfield SB, Aronne LJ, Montgomery P, et al.; BELIEVE trial investigators. Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. Nat Med. 2026;32(3):869-882. [PubMed 41772149](https://pubmed.ncbi.nlm.nih.gov/41772149/)
4. Eli Lilly and Company. Safety and efficacy of bimagrumab and semaglutide in adults who are overweight or obese (BELIEVE, NCT05616013). ClinicalTrials.gov results: body weight and lean mass by DXA at week 48. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05616013)
5. Pratley RE, Denham DS, Trivedi R, et al. Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial (EMBRAZE). Nat Med. 2026;32(7):2673-2678. [PubMed 42260100](https://pubmed.ncbi.nlm.nih.gov/42260100/)
6. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity. 2025;33(8):1475-1503. [PubMed 40445127](https://pubmed.ncbi.nlm.nih.gov/40445127/)
7. Lundgren JR, Janus C, Jensen SBK, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med. 2021;384(18):1719-1730. [PubMed 33951361](https://pubmed.ncbi.nlm.nih.gov/33951361/)
8. Kim JY, Kim NH. Beyond fat loss: addressing the sarcopenia challenge of incretin-based therapies. Diabetes Metab J. 2026;50(5):844-862. [PubMed 42722378](https://pubmed.ncbi.nlm.nih.gov/42722378/)
9. Scholar Rock, Inc. ISEMBYLD (apitegromab-mstn) injection, prescribing information (DailyMed, version 3, Sep 2026): indicated for spinal muscular atrophy; initial US approval 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1cd8ab8-8a10-48ed-9806-75a44f22b963)
10. Coskun T, Wu Q, Schloot NC, et al. Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial. Lancet Diabetes Endocrinol. 2025;13(8):674-684. [PubMed 40609566](https://pubmed.ncbi.nlm.nih.gov/40609566/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)

Intermittent fasting on a GLP-1: what the fasting trials found, why no trial has tested the pair, and what the labels say on blood sugar, fluids and protein.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)
- [Retatrutide Studied range: 1–12 mg](https://pepvault.app/peptides/retatrutide)

## Related guides

- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · GLP-1s

  ### [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)

  What to expect on retatrutide week by week: the trial dose steps, when appetite drops, weight loss at weeks 24, 48 and 80, and how side effects settle.

  Read the guide
- Guide · Stacks

  ### [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)

  What to pair with each peptide, and why: glycine and vitamin C for repair, less zinc on GHK-Cu, fasting and sleep for GH peptides, protein on GLP-1s.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)
- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)
- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
